The Goldman Sachs Group, Inc. 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 4:52 pm Sale |
2023-12-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
GOLDMAN SACHS GROUP INC GS |
2,007,447 2.500% |
-1,828,712 (-47.67%) |
Filing |
| 2023-02-08 09:52 am Purchase |
2022-12-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
GOLDMAN SACHS GROUP INC GS |
3,836,159 5.700% |
212,914 (+5.88%) |
Filing |
| 2022-02-02 1:03 pm Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
GOLDMAN SACHS GROUP INC GS |
3,623,245 6.200% |
3,623,245 (New Position) |
Filing |